title: MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.
abstract: The apparent diffusion coefficient (ADC) determined from MR diffusion tensor imaging (DTI) has shown promise for distinguishing World Health Organization grade II astrocytoma (AS) from the more prognostically favorable grade II oligodendroglioma (OD). Since mixed oligoastrocytomas (OAs) with codeletions in chromosomes 1p and 19q confer prognoses similar to those of OD, we questioned whether a previously determined ADC-based criterion for distinguishing OD and AS would hold on an independent set of gliomas that included OA with codeleted or intact 1p/19q chromosomes. We also questioned whether the ADC is associated with the tumor microstructure. ADC colormaps generated from presurgical DTI scans were used to guide the collection of biopsies from each tumor. The median normalized ADC distinguished OD from AS with 91% sensitivity and 92% specificity. 1p/19q codeleted OAs were always classified as ODs, while 1p/19q intact OAs were always classified as ASs. There were positive associations between the ADC and both the SMI-31 score of axonal disruption and the fraction of tumor cells in the biopsies. The ADC of OD and 1p/19q codeleted OA was more associated with tumor fraction, while the ADC of AS and 1p/19q intact OA was more associated with SMI-31 score. We conclude that our previously determined threshold median ADC can distinguish grade II OD and AS on a new patient cohort and that the distinctions extend to OA with codeleted and intact 1p/19q chromosomes. Further, the ADC in grade II gliomas is associated with the fraction of tumor cells and degree of axonal disruption in tumor subregions.
authors.affiliation: UCSF/UCB Joint Graduate Group in Bioengineering, University of California, San Francisco, CA, USA.
authors.forename: Inas S
authors.initials: IS
authors.lastname: Khayal
authors.forename: Scott R
authors.initials: SR
authors.lastname: Vandenberg
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Smith
authors.forename: Colleen P
authors.initials: CP
authors.lastname: Cloyd
authors.forename: Susan M
authors.initials: SM
authors.lastname: Chang
authors.forename: Soonmee
authors.initials: S
authors.lastname: Cha
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Nelson
authors.forename: Tracy R
authors.initials: TR
authors.lastname: McKnight
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001254:Astrocytoma / Q000145:classification / Q000235:genetics / Q000473:pathology*; D001932:Brain Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology*; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D015331:Cohort Studies; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009837:Oligodendroglioma / Q000145:classification / Q000235:genetics / Q000473:pathology*; D011379:Prognosis; D012372:ROC Curve